Regulatory compliance and ethical considerations are essential for ensuring the safe development of regenerative therapies. This session will focus on global regulatory frameworks governing tissue-engineered products and advanced therapies. Researchers will discuss ethical challenges associated with emerging biomedical technologies. Recent policy developments will also be highlighted.
Presentations will examine approval pathways, quality standards, and safety assessment procedures. Participants will gain insights into international guidelines for clinical research and product commercialization. Discussions will also address ethical issues related to stem cells, gene editing, and patient consent. Best practices for responsible innovation will be emphasized.
The session will address future regulatory trends and evolving ethical frameworks in regenerative medicine. Experts will discuss strategies for balancing innovation with patient safety. Collaboration among regulatory agencies, researchers, and industry stakeholders will be encouraged. This session aims to promote responsible scientific advancement.